Bevacizumab Injectable Product

DRUG2 trials

Sponsors

Lions Eye Institute, Perth, Western Australia, National Cancer Center, Korea

Conditions

Diabetic Macular EdemaDiabetic RetinopathyLazertinib

Phase 2

A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker

RecruitingNCT06156527

National Cancer Center, KoreaLazertinib

Start: 2023-09-05End: 2026-12-31Target: 120Updated: 2023-12-05

Phase 4

Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO

CompletedNCT04619303

Lions Eye Institute, Perth, Western AustraliaDiabetic Macular Edema, Diabetic Retinopathy

Start: 2017-02-07End: 2020-02-14Updated: 2020-11-09

Related Papers

99TiP A randomized phase II study of lazertinib alone versus lazertinib plus bevacizumab for advanced non-small cell lung cancer with epidermal growth factor receptor activating mutations and smoking history

ESMO Open2024-03-01